Understand the source comparison
Can You Stack FOXO4-DRI Other Peptides: Comparison
Senolytic FOXO4-DRI FOXO4-p53 disruption → apoptosis in senescent cells Primary compound N/A (baseline) Initiates the clearance cascade. All other peptides are timed around this Tissue Repair BPC-157 VEGF upregulation, integrin signaling, fibroblast migration
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Senolytic
- FOXO4-DRI
- FOXO4-p53 disruption → apoptosis in senescent cells
- Primary compound
- N/A (baseline)
- Initiates the clearance cascade. All other peptides are timed around this
- Tissue Repair
- BPC-157
- VEGF upregulation, integrin signaling, fibroblast migration
- 48–72 hours after
- Independent pathways, synergistic when staggered
- Ideal pairing. FOXO4-DRI clears damage, BPC-157 rebuilds tissue
- GH Secretagogue
- MK 677
- Ghrelin receptor agonism → GH and IGF-1 elevation
- 24–48 hours after
- Independent but anabolic signals counterproductive during apoptosis
- Compatible if dosed after clearance phase completes
- Immune Modulator
- Thymalin
- T-cell differentiation, thymic peptide signaling
- 48–72 hours before, or concurrent
- Enhances immune clearance capacity
- Pre-dosing Thymalin primes macrophage activity for debris clearance
- Anti-Inflammatory
- KPV 5MG
- NF-κB inhibition, reduced cytokine production
- 18–24 hours after
- Dampens post-apoptotic inflammation without blocking clearance
- Useful for mitigating transient cytokine spike. Dose after peak apoptosis
- Nootropic/Neurogenic
- Dihexa
- HGF/c-Met pathway activation, synaptogenesis
- Independent. Neurogenic effects unrelated to senolytic pathways
- Safe to stack if dosed after clearance; no receptor overlap